| Idorsia Ltd.. (7/1/24). "Press Release: Idorsia’s Jeraygo (aprocitentan) Approved in Europe as First and Only ERA for the Treatment of Resistant Hypertension". Allschwil. |
2024-07-01 |
| Valneva S.E.. (7/1/24). "Press Release: Valneva Receives Marketing Authorization in Europe for the World’s First Chikungunya Vaccine, Ixchiq". Saint Herblain. |
2024-07-01 |
| N-Power Medicine, Inc.. (7/1/24). "Press Release: N-Power Medicine Emerges with Series B Funding to Bolster Access to Innovative Oncology Clinical Trials". Redwood City, CA. |
2024-07-01 |
| BioM Biotech Cluster Development GmbH. (6/26/24). "Press Release: MAxL in Martinsried. Bio M Opens New Start-up Incubator – 8.5 Million Euros for Innovative Start-up Teams to Strengthen Biotechnology in Bavaria". |
2024-06-26 |
| Evotec SE. (6/25/24). "Press Release: Just – Evotec Biologics Selected by U.S. Department of Defense for Manufacturing Optimization Program". Hamburg. |
2024-06-25 |
| Proscia Inc.. (6/25/24). "Press Release: Proscia and Nucleai Partner to Broaden Access to AI Predictive Biomarkers". Philadeliphia, PA & Chicago, IL. |
2024-06-25 |
| CatSci Ltd.. (6/25/24). "Press Release: CatSci Announces Strategic Acquisition of Reach Separations to Offer End-To-End Separation Science Support from Discovery to Manufacture". |
2024-06-25 |
| BioNTech SE. (6/24/24). "Press Release: BioNTech and DualityBio Receive FDA Fast Track Designation for Antibody-Drug Conjugate Candidate BNT324/DB-1311 in Prostate Cancer". Mainz & Shanghai. |
2024-06-24 |
| Merck KGaA. (6/24/24). "Press Release: Merck Provides Update on Xevinapant Program in Locally Advanced Head and Neck Cancer [ Not intended for UK-, US- or Canada-based media ]". Darmstadt. |
2024-06-24 |
| Allecra Therapeutics GmbH. (6/24/24). "Press Release: Allecra Therapeutics and Acino Sign Exclusive Licensing and Supply Agreement for Allecra’s Novel Antibiotic Exblifeb in Gulf Cooperation Council countries and South Africa". Saint-Louis, Weil am Rhein |
2024-06-24 |
| InflaRx N.V.. (6/24/24). "Press Release: InflaRx’s Gohibic (vilobelimab) Selected for First BARDA-sponsored Clinical Trial to Evaluate Novel Host-directed Therapeutics for Acute Respiratory Distress Syndrome (ARDS)". Jena. |
2024-06-24 |
| NLC Ventures Netherlands B.V.. (6/24/24). "Press Release: NLC Health Ventures Launches New Early-stage Drug Delivery Company". |
2024-06-24 |
| Tecan Group Ltd.. (6/24/24). "Press Release: Tecan Appoints Mukta Acharya Head of the Life Sciences Business Division". Männedorf. |
2024-06-24 |
| Evotec SE. (6/24/24). "Press Release: beLAB1407 to Develop Novel Approach for Cardiovascular Diseases". Hamburg. |
2024-06-24 |
| DataHow AG. (6/21/24). "Press Release: DataHow Secures Series A investment for Its AI Bioprocessing Solutions". |
2024-06-21 |
| Charité – Universitätsmedizin Berlin. (6/21/24). "Press Release: Together for Innovation. Charité and Bayer Establish Berlin Center for Gene and Cell Therapies". |
2024-06-21 |
| ITM Isotope Technologies Munich SE. (6/20/24). "Press Release: ITM Appoints Dr. Andrew Cavey as CEO to Lead Organization in its Next Stage of Growth". Garching. |
2024-06-20 |
| iOnctura B.V.. (6/20/24). "Press Release: iOnctura Announces EUR80 Million Series B Financing to Progress Pipeline through Phase II Trials". Geneva & Amsterdam. |
2024-06-20 |
| High-Tech Gründerfonds Management GmbH. (6/20/24). "Press Release: Health Tech Start-up Carelane Raises €800,000 in Pre-Seed Funding to Revolutionize Clinical Trial Software". |
2024-06-20 |
| X-Chem, Inc.. (6/20/24). "Press Release: X-Chem Strengthens Its Data-Driven Discovery Services with New CBO Appointment". Watertown, MA. |
2024-06-20 |
| Forbion Capital Partners. (6/20/24). "Press Release: Forbion Announces First Close of Its New BioEconomy Fund I – Backing Biotech-enabled Companies Aiming to Impact the Future of Our Planet". Amsterdam. |
2024-06-20 |
| Wacker Chemie AG. (6/19/24). "Press Release: Wacker & CordenPharma Enter Pandemic Readiness on 1 June 2024 After Successful Expansion & Qualification". Munich, Halle (Saale) & Basel. |
2024-06-19 |
| Sidekick Health. (6/18/24). "Press Release: Sidekick Health Expands Oncology and Women's Health Portfolio with Acquisition of PINK! in Germany". Amsterdam. |
2024-06-18 |
| NXI Therapeutics AG. (6/18/24). "Press Release: NXI Therapeutics Extends Pre-Seed Financing to CHF 3.5 Million in Run-up to Larger Seed Financing". Basel. |
2024-06-18 |
| Marea Therapeutics. (6/18/24). "Press Release: Marea Therapeutics Launches with $190 Million to Accelerate a New Generation of Medicines for Cardiometabolic Diseases". South San Francisco, CA. |
2024-06-18 |
| Ethris GmbH. (6/18/24). "Press Release: Ethris Announces $5 Million in Funding to Prepare Lead Candidate ETH47 for Phase 2 Stud". Munich. |
2024-06-18 |
| Traceless Materials GmbH. (6/18/24). "Press Release: Female-founded Bioeconomy Start-up Traceless Partners with Mondi to Scale Natural, Regenerative Solutions in Paper Coating". Hamburg. |
2024-06-18 |
| Forbion Capital Partners. (6/18/24). "Press Release: Forbion Co-leads $190 Million Financing of Marea Therapeutics". Naarden. |
2024-06-18 |
| Santhera Pharmaceuticals Holding AG. (6/18/24). "Press Release: Santhera Secures up to CHF 69 million in Royalty and Debt Financing to Fund Operations to Cash Flow Break-Even (Ad hoc announcement pursuant to Art. 53 LR)". Pratteln. |
2024-06-18 |
| AdBio Partners SAS. (6/18/24). "Press Release: Inserm Transfert and AdBio Partners Launch AndzonBio". Paris. |
2024-06-18 |
| Ethris GmbH. (6/18/24). "Press Release: Cipla EU to Invest an Additional EUR 3 Million in Ethris". Mumbai & Munich. |
2024-06-18 |
| Hikma Pharmaceuticals plc. (6/17/24). "Press Release: Hikma Acquires Xellia’s Differentiated Portfolio and Enhances Injectables Pipeline, Manufacturing Capabilities and R&D". London. |
2024-06-17 |
| High-Tech Gründerfonds Management GmbH. (6/12/24). "Press Release: New component for Germany’s Future Fund – HTGF Opportunity Fund Launches with €660 Million for Growth-phase Investments". |
2024-06-12 |
| T-Therapeutics Ltd.. (6/12/24). "Press Release: T-Therapeutics Appoints Dr David Hung as Chairman". Cambridge. |
2024-06-12 |
| Berlin Institute of Health. (6/12/24). "Press Release: New Perspectives for Patients. National Strategy for Gene and Cell Therapies Presented to the BMBF". |
2024-06-12 |
| SciRhom GmbH. (6/12/24). "Press Release: SciRhom Announces Approval of First Clinical Trial Application for a Novel iRhom2-targeting Antibody Against Autoimmune Diseases". Munich. |
2024-06-12 |
| Evotec SE. (6/12/24). "Press Release: Evotec Announces Progress in Neuroscience Collaboration with Bristol Myers Squibb". Hamburg. |
2024-06-12 |
| Coulter Partners. (6/12/24). "Press Release: Coulter Partners Announces Leadership Transition and Senior Leadership Team (SLT) Reorganization: Co-founder Bianca Coulter Becomes Executive Chair, Nicholas Green Appointed CEO". |
2024-06-12 |
| Moleculent AB. (6/11/24). "Press Release: Moleculent Launches with $26 Million Series A Financing to Advance the Spatial Mapping of Cell-Cell Communication". Stockholm. |
2024-06-11 |
| Adcytherix SAS. (6/11/24). "Press Release: Adcytherix Launches with € 30m in Seed Funding to Develop Next Generation Antibody Drug Conjugates". Marseille. |
2024-06-11 |
| Thermosome GmbH. (6/11/24). "Press Release: Thermosome Appoints Dr. Sabine Hauck as Chief Technical Officer". Munich. |
2024-06-11 |
| Tacalyx GmbH. (6/11/24). "Press Release: Tacalyx Extends Seed Round to over €14 M to Advance Development of its Cancer Therapeutics Targeting TACAs". Berlin. |
2024-06-11 |
| Bright Peak Therapeutics AG. (6/11/24). "Press Release: Bright Peak Therapeutics Announces $90 Million in Series C Financing to Advance First-in-Class PD1-IL18 Immunoconjugate Program Into Clinical Trials". Basel & San Diego, CA. |
2024-06-11 |
| Macomics Ltd.. (6/10/24). "Press Release: Macomics Announces Appointment of Simon Dew as New Chief Business Officer". Edinburgh & Cambridge. |
2024-06-10 |
| Evotec SE. (6/10/24). "Press Release: Results of the Annual General Meeting 2024". Hamburg. |
2024-06-10 |
| Amber Therapeutics Ltd.. (6/10/24). "Press Release: Amber Therapeutics Closes $100 Million Series A Financing to Advance Breakthrough Amber-UI Neuromodulation Therapy for Mixed Urinary Incontinence towards US FDA Approval". London. |
2024-06-10 |
| Ipsen S.A.. (6/10/24). "Press Release: Ipsen’s Iqirvo Receives U.S. FDA Accelerated Approval as a First-in-Class PPAR Treatment for Primary Biliary Cholangitis". Paris. |
2024-06-10 |
| GSK plc. (6/6/24). "Press Release: GSK Accelerates Oligonucleotide Platform and Pipeline Medicines with Acquisition of Elsie Biotechnologies [For media and investors only]". London. |
2024-06-06 |
| ITM Isotope Technologies Munich SE. (6/6/24). "Press Release: ITM Raises €188m to Enhance Radiopharmaceutical Pipeline and to Strengthen Leading Position in Medical Radioisotope Manufacturing". Garching. |
2024-06-06 |
| MorphoSys AG. (6/6/24). "Press Release: Arkadius Pichota and Lukas Gilgen Appointed to Management Board of MorphoSys AG Replacing the Current CEO and CFO (Ad hoc)". Planegg. |
2024-06-06 |
| Seres Therapeutics, Inc.. (6/6/24). "Press Release: Seres Therapeutics Enters into Memorandum of Understanding for Vowst Asset Sale to Nestlé Health Science". Cambridge, MA. |
2024-06-06 |
| Sartorius AG. (6/5/24). "Press Release: Sartorius Opens New Center of Excellence for Bioanalytics in Ann Arbor". Ann Arbor, MI. |
2024-06-05 |
| Quantro Therapeutics GmbH. (6/4/24). "Press Release: Quantro Therapeutics Reaches a Milestone in the Collaboration with Boehringer Ingelheim to Develop First-in-Class Cancer Treatments". Vienna. |
2024-06-04 |
| AdBio Partners SAS. (6/4/24). "Press Release: AdBio Partners Promotes Emma Gasol to Partner". Paris & Barcelona. |
2024-06-04 |
| Brandon Capital. (6/4/24). "Press Release: Brandon Capital Announces Sixth Fund with A$270 Million (US$180 Million) Initial Close to Drive Life Science Innovation". Melbourne. |
2024-06-04 |
| BenevolentAI S.A.. (6/4/24). "Press Release: BenevolentAI to participate in Goldman Sachs 45th Annual Global Healthcare Conference". |
2024-06-04 |
| Annogen B.V.. (6/4/24). "Press Release: Annogen Announces Research Collaboration with Orchard Therapeutics for the Development of CNS-cell Specific Promoters". Amsterdam. |
2024-06-04 |
| University of Frankfurt. (6/3/24). "Press Release: Goethe University Frankfurt Founds Institute for Digital Medicine". |
2024-06-03 |
| SolasCure Ltd.. (6/3/24). "Press Release: SolasCure Selected for Innovate UK Global Incubator Programme in Houston". Cambridge. |
2024-06-03 |
| DefiniGen Ltd.. (6/3/24). "Press Release: DefiniGen and Atelerix Collaborate to Ship in vitro Cell Models Internationally without the Need for Freezing or Cryopreservation". Cambridge & Newcastle. |
2024-06-03 |
| Bicycle Therapeutics plc. (6/3/24). "Press Release: Bicycle Therapeutics to Participate in Upcoming Investor Conferences". Cambridge & Boston, MA. |
2024-06-03 |
| Wacker Chemie AG. (6/3/24). "Press Release: Wacker Opens mRNA Competence Center in Halle an der Saale, Germany". Munich & Halle (Saale). |
2024-06-03 |
| NLC Ventures Netherlands B.V.. (6/3/24). "Press Release: Dutch Health Insurer VGZ Invests €6 Million in NLC Health Ventures". |
2024-06-03 |
| PhoreMost Ltd.. (6/3/24). "Press Release: PhoreMost Achieves Second Milestone in Target Discovery Alliance with Boehringer Ingelheim". Cambridge. |
2024-06-03 |
| Evotec SE. (6/3/24). "Press Release: Evotec and Qiagen Enter Software Collaboration for Enhanced Multi-omics Data Insights". Hamburg & Venlo. |
2024-06-03 |
| Ardena Holding N.V.. (6/3/24). "Press Release: Ardena Appoints Jeremie Trochu as Chief Executive Officer". Ghent. |
2024-06-03 |
| Nyxoah S.A.. (5/31/24). "Press Release: Nyxoah Announces Closing of Offering and Partial Exercise of Option to Purchase Additional Shares". Mont-Saint-Guibert. |
2024-05-31 |
| Evotec SE. (5/30/23). "Press Release: Evotec, Inserm, Lille University Hospital and Inserm Transfert Enter Collaboration to Identify Novel Therapeutic Targets in Obesity and Metabolic Diseases". Hamburg. |
2024-05-30 |
| High-Tech Gründerfonds Management GmbH. (5/30/24). "Press Release: Unlocking Soil Carbon. Berlin-based Climate Tech Startup Seqana Raises €2.1M Seed Round to Unlock Scalable Carbon Farming on 6 Continents from Space". Berlin. |
2024-05-30 |
| Adaptimmune Therapeutics plc. (5/30/24). "Press Release: Adaptimmune and Galapagos Sign Clinical Collaboration Agreement with an Option to Exclusively License Adaptimmune's TCR T-cell Therapy Candidate, uza-cel, in Head & Neck Cancer and Potential Future |
2024-05-30 |
| BlueRock Therapeutics LP. (5/30/23). "Press Release: BlueRock Therapeutics Receives FDA Regenerative Medicine Advanced Therapy Designation for Parkinson’s Disease Cell Therapy Candidate Bemdaneprocel". Berlin & Cambridge, MA. |
2024-05-30 |
| Nagi Bioscience S.A.. (5/30/24). "Press Release: Nagi Bioscience Makes a Strong Debut at BIO International as Part of the Innosuisse Cohort for the Swiss Pavilion". Saint-Sulpice. |
2024-05-30 |
| ExpressionEdits Ltd.. (5/29/24). "Press Release: ExpressionEdits Raises $13M in Seed Funding to Advance Protein Expression Using AI-Driven Intronization Technology". Cambridge. |
2024-05-29 |
| BRAIN Biotech AG. (5/29/24). "Press Release: BRAIN Biotech AG Announces the Appointment of Erik de Vries as Senior Business Development Director Enzymes". Zwingenberg & Greifswald. |
2024-05-29 |
| Cellular Origins Ltd.. (5/29/24). "Press Release: Cellular Origins and Cell and Gene Therapy Catapult Collaborate to Demonstrate Universal Automation of CGT Manufacturing". Cambridge & Stevenage. |
2024-05-29 |
| Merck KGaA. (5/29/24). "Press Release: Merck Signs MoU with KAIST to Advance Scientific Collaboration". Darmstadt. |
2024-05-29 |
| Fresenius SE & Co. KGaA. (5/29/24). "Press Release: Fresenius Appoints Internationally Experienced Biopharma Expert to the Fresenius Kabi Management Board". |
2024-05-29 |
| Adcendo ApS. (5/29/24). "Press Release: Adcendo ApS Announces Extension of Series A Financing to EUR 98M to Further Bolster its First-in-Class ADC Pipeline". Copenhagen. |
2024-05-29 |
| ProBioGen AG. (5/29/24). "Press Release: ModeX Therapeutics Leverages ProBioGen's Expertise for Accelerated COVID-19 Antibody Development". Berlin. |
2024-05-29 |
| Merck & Co., Inc.. (5/29/24). "Press Release: Merck to Acquire EyeBio". Rahway, NJ & New York, NY. |
2024-05-29 |
| BioNTech SE. (5/29/24). "Press Release: BioNTech and CEPI Expand Partnership to Strengthen Africa’s mRNA Vaccine Ecosystem". Mainz & Oslo. |
2024-05-29 |
| Origenis GmbH. (5/28/24). "Press Release: OncoBone Ventures and Origenis Announce Partnership to Develop Novel Therapies for Cancer Bone Metastasis". Tübingen & Boston, MA. |
2024-05-28 |
| Asahi Kasei Corporation. (5/28/24). "Press Release: Asahi Kasei to Acquire Calliditas Therapeutics AB to Accelerate Growth as a Global Healthcare Company". |
2024-05-28 |
| CureVac N.V.. (5/28/24). "Press Release: CureVac Announces Dosing of First Participant in a Phase 2 Study in Seasonal Influenza; Development in Collaboration with GSK". Tübingen & Boston, MA. |
2024-05-28 |
| Numab Therapeutics AG. (5/28/24). "Press Release: Numab Therapeutics Announces Johnson & Johnson to Acquire its Wholly-Owned Subsidiary Yellow Jersey Therapeutics Including Rights to NM26, a Bi-Specific Antibody for the Treatment of Atopic Dermatitis". H |
2024-05-28 |
| TVM Capital Healthcare. (5/28/24). "Press Release: TVM Capital Healthcare Announces the Closing of Its Saudi Arabia-Focused TVM Healthcare Afiyah Fund
". Riyadh. |
2024-05-28 |
| Spectrum.Life. (5/27/24). "Press Release: Spectrum.Life Closes €17M Investment Round to Accelerate International Growth". London. |
2024-05-27 |
| Hitachi High-Tech Corporation. (5/27/24). "Press Release: Roche and Hitachi High-Tech Extend Their Long-standing Partnership". Tokyo. |
2024-05-27 |
| Eisbach Bio GmbH. (5/24/24). "Press Release: Eisbach Bio Announces Successful Completion of Phase I Clinical Trial of Nucleic Acid Helicase Inhibitor EIS-10700 with Excellent Safety Properties". Martinsried. |
2024-05-24 |
| Radar Therapeutics Inc.. (5/23/24). "Press Release: Radar Therapeutics Raises $13.4M in Seed Funding to Develop Smart Programmable Medicines Using Molecular RNA Sensors". Berkeley, CA. |
2024-05-23 |
| Orna Therapeutics, Inc.. (5/23/24). "Press Release: Orna Therapeutics Announces Strategic Acquisition of ReNAgade Therapeutics to Solidify Leadership in Circular RNA Therapies". Watertown, MA & Cambridge, MA. |
2024-05-23 |
| Merck KGaA. (5/22/24). "Press Release: Merck Signs Definitive Agreement to Acquire Life Science Company Mirus Bio for US$ 600 million". Darmstadt. |
2024-05-22 |
| Deepull Diagnostics S.L.. (5/22/24). "Press Release: Deepull Appoints Didier Deltort to Its Board of Directors". Barcelona. |
2024-05-22 |
| Biogen Inc.. (5/22/24). "Press Release: Biogen Bolsters Late-Stage Pipeline, Expands Immunology Portfolio with Agreement to Acquire Human Immunology Biosciences". Cambridge, MA & South San Francisco, CA. |
2024-05-22 |
| Daiichi Sankyo Co., Ltd.. (5/22/24). "Press Release: Daiichi Sankyo Establishes Two Research Institutes in the U.S. and EU". |
2024-05-22 |
| SixPeaks Bio AG. (5/22/24). "Press Release: SixPeaks Bio AG Debuts With $110 Million in Funding". Basel. |
2024-05-22 |
| Refeyn Ltd.. (5/22/24). "Press Release: Refeyn Announces Appointment of Fiona Coats as Chief Marketing Officer". Oxford. |
2024-05-22 |
| Jeito Capital. (5/22/24). "Press Release: Jeito Capital Announces Acquisition of Portfolio Company HI-Bio by Biogen Inc. (Nasdaq: BIIB) for up to $1.8 Billion". Paris. |
2024-05-22 |
| BioNTech SE. (5/22/24). "Press Release: BioNTech to Evaluate NanoTag’s Target Labeling System in Different Therapeutic Areas". Mainz & Göttingen. |
2024-05-22 |
| Meatable. (5/22/24). "Press Release: Meatable Appoints U.S.-based Meat industry Veteran Jeff Tripician as New CEO". Leiden. |
2024-05-22 |
![[LSE] Life-Sciences-Europe.com - The European Life Sciences Web Portal](/images/basics/lse-life-sciences-europe-portal-logo.svg){kind=logo}
1 2 3 4 ... 64 65 66 
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
